Immuron presentation australian biologics festival 2024

Melbourne, australia, feb. 21, 2024 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company is pleased to advise our research & development manager, joanne casey, phd will be presenting at the australian biologics festival 2024 on wednesday, 21st february in melbourne, australia.

IMRN Ratings Summary

IMRN Quant Ranking